{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-102498","form_type":"8-K","ticker":"HUMA","cik":"0001818382","company_name":"Humacyte, Inc.","filed_at":"2024-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.647466+00:00","generated_at":"2026-05-31T01:53:29.299178+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Humacyte enters $50M equity purchase agreement with Lincoln Park Capital","bullets":["Company can sell up to $50M of common stock to Lincoln Park over 24 months at its discretion.","Purchase price is 97% of the lower of the daily low or average of three lowest closing prices over prior 10 days.","Shares not sold below $1.00 floor price; maximum regular purchase of 100,000 shares or $1.5M per day.","Commitment fee of 115,705 shares issued to Lincoln Park; net proceeds for R&D, commercial launch, and working capital.","Lincoln Park agrees not to engage in short-selling or hedging during the term."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-102498","json":"https://secwatch.observer/filing/0001104659-24-102498.json","markdown":"https://secwatch.observer/filing/0001104659-24-102498.md","text":"https://secwatch.observer/filing/0001104659-24-102498.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818382/000110465924102498/0001104659-24-102498-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818382/000110465924102498/tm2424623d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:53:29.299178+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}